scholarly journals In Low- And Middle-Income Countries, Is Delivery In High-Quality Obstetric Facilities Geographically Feasible?

2019 ◽  
Vol 38 (9) ◽  
pp. 1576-1584 ◽  
Author(s):  
Anna D. Gage ◽  
Fei Carnes ◽  
Jeff Blossom ◽  
Jalemba Aluvaala ◽  
Archana Amatya ◽  
...  
Keyword(s):  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

scholarly journals Core outcome set in paediatric sepsis in low- and middle-income countries: a study protocol

BMJ Open ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. e034960
Author(s):  
Gavin Wooldridge ◽  
Srinivas Murthy ◽  
Niranjan Kissoon
Keyword(s):  
Study Protocol ◽  
Core Outcome Set ◽  
Core Outcome ◽  
High Quality ◽  
Middle Income ◽  
Ongoing Research ◽  
Middle Income Countries ◽  
Outcome Set ◽  
Low Middle Income Countries ◽  
Low And Middle Income

IntroductionSepsis is the leading cause of death in children worldwide and has recently been declared a major global health issue. New interventions and a concerted effort to enhance our understanding of sepsis are required to address the huge burden of disease, especially in low- and middle-income countries (LMIC) where it is highest. An opportunity therefore exists to ensure that ongoing research in this area is relevant to all stakeholders and is of consistently high quality. One method to address these issues is through the development of a core outcome set (COS).Methods and analysisThis study protocol outlines the phases in the development of a core outcome set for paediatric sepsis in LMIC. The first step involves performing a systematic review of all outcomes reported in the research of paediatric sepsis in low middle-income countries. A three-stage international Delphi process will then invite a broad range of participants to score each generated outcome for inclusion into the COS. This will include an initial two-step online survey and finally, a face-to-face consensus meeting where each outcome will be reviewed, voted on and ratified for inclusion into the COS.Ethics and disseminationNo core outcome sets exist for clinical trials in paediatric sepsis. This COS will serve to not only highlight the heavy burden of paediatric sepsis in this setting and aid collaboration and participation between all stakeholders, but to promote ongoing essential high quality and relevant research into the topic. A COS in paediatric sepsis in LMIC will advocate for a common language and facilitate interpretation of findings from a variety of settings. A waiver for ethics approval has been granted by University of British Columbia Children’s and Women’s Research Ethics Board.

scholarly journals Participation and Achievement in the Summer Paralympic Games: The Influence of Income, Sex, and Assistive Technology

2021 ◽  
Vol 13 (21) ◽  
pp. 11758
Author(s):  
Giulia Oggero ◽  
Louise Puli ◽  
Emma Maria Smith ◽  
Chapal Khasnabis
Keyword(s):  
Assistive Technology ◽  
Income Level ◽  
High Income ◽  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low Middle Income Countries ◽  
Significant Difference ◽  
Paralympic Games ◽  
Low And Middle Income

Global participation at the Paralympic Games has been steadily growing in the past 60 years. However, inequities in relation to geographic representation of Paralympians, sex representation, access to assistive technology, and medal success remain. The objectives of this research are to describe and compare trends in Paralympians’ participation and achievements in the Summer Paralympic Games by income level and sex, including in events requiring assistive products (wheelchairs, hand cycles/trikes, and prostheses). A retrospective secondary analysis of publicly available data was conducted. Participation, sex, and medal tally data were extracted from data available on the International Paralympic Committee website and archives. Data regarding income and population were collected from publicly available data available from the World Bank website. Participation in the Summer Paralympic Games differs significantly by income level (p = 0.000) with high- income countries sending, on average, more Paralympians than low- and middle-income countries. There is a significant difference between male and female participation (p = 0.00), with approximately 29% of all Paralympians being female. High-income countries demonstrate significantly higher achievement than low- and middle-income countries (p = 0.000), including in events requiring assistive products (p = 0.007). Despite growth in overall participation, low- and middle-income countries remain severely underrepresented in both participation and achievement at the Paralympic Games, especially in the events that require high quality assistive products to succeed. More equitable participation and achievement in the Paralympics may be supported by addressing the barriers for females, for people from low- and low-middle income countries, and for those without access to high quality assistive products required.

Effect of Disability on High Quality of Life among Older Adults in Low and Middle-income Countries

2021 ◽  
Author(s):  
Mohammad Hifz Ur Rahman ◽  
Shobhit Srivastava ◽  
Pradeep Kumar ◽  
Ashish Singh ◽  
Deepak Gupta ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Older Adults ◽  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

scholarly journals Cancer Control in Low- and Middle-Income Countries

2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 153s-153s
Author(s):  
F. Humura
Keyword(s):  
Sustainable Development ◽  
Developing Countries ◽  
Health Services ◽  
Sustainable Development Goals ◽  
Cancer Control ◽  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Development Goals ◽  
Low And Middle Income

Background: Cancer is also referred to as malignant tumor or neoplasm. It is one of the leading causes of death on the global scale. The knowledge and tools to manage and even cure cancer patients exist in developed countries but are unavailable to many who live in the developing world, resulting in unnecessary loss of life. Strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. It is also pertinent to bridge the gap to ensure universal health coverage which is very important to achieve the sustainable development goals. Aim: The aim of this abstract is to review the barrier to cancer control in developing world especially the low-and middle-income countries. Method: Selected papers amounting to 79 papers in PubMed from 2007 to 2017 were used from peer-reviewed literature and relevant publicly available documents with the appropriate keywords searched. Results: In spite of significant limitations in the available data, it is clear there are substantial barriers to access to cancer control in developing countries and also substantial limitations in the quality of cancer control and a great need to improve economic efficiency. Cancer is low or absent on the health agendas of low- and middle-income countries (LMCs) despite the fact that more people die of cancer in these countries than from AIDS and malaria combined. International health organizations, bilateral aid agencies, and major foundations which are instrumental in setting health priorities also have largely ignored cancer in these countries. Conclusion: and recommendations: There is an urgent need to improve health services for cancer control in developing countries to ensure health equity which is one of the key areas to be addressed in other to achieve sustainable development goals. Current resources and much-needed investments must be optimally managed. To achieve this, recommended investment should be focused in the following key priorities: capacity building in oncology health services research, policy and planning relevant to developing countries, development of high-quality health data sources, more oncology-related economic evaluations in developing countries, exploration of high-quality models of cancer control in developing countries. Meeting these needs will require national, regional and international collaboration as well as political leadership. Horizontal integration with programs for other diseases will be important.

scholarly journals Decentralization and Regionalization: Redesigning Health Systems for High Quality Maternity Care Comment on "Decentralization and Regionalization of Surgical Care: A Review of Evidence for the Optimal Distribution of Surgical Services in Low- and Middle-Income Countries"

2020 ◽  
Author(s):  
Sanam Roder-DeWan
Keyword(s):  
Health System ◽  
Health Systems ◽  
Maternity Care ◽  
Quality Care ◽  
Surgical Care ◽  
Maternal Complications ◽  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

The question of how to optimally design health systems in low- and middle-income countries (LMICs) for high quality care and survival requires context-specific evidence on which level of the health system is best positioned to deliver services. Given documented poor quality of care for surgical conditions in LMICs, evidence to support intentional health system design is urgently needed. Iverson and colleagues address this very important question. This commentary explores their findings with particular attention to how they apply to maternity care. Though surgical maternity care is a common healthcare need, maternal complications are often unpredictable and require immediate surgical attention in order to avert serious morbidity or mortality. A discussion of decentralization for maternity services must grapple with this tension and differentiate between facilities that can provide emergency surgical care and those that can not.

scholarly journals Challenges of clinical trials in low- and middle-income countries

2012 ◽  
Vol 9 (2) ◽  
pp. 30-31
Author(s):  
Akwasi Osei
Keyword(s):  
Clinical Trials ◽  
Low Income ◽  
High Income ◽  
International Standards ◽  
Low Income Countries ◽  
Profit Motive ◽  
High Quality ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income

Clinical trials have been conducted almost wholly in high-income countries until recently, yet their results may not always be valid or applicable in middle- and low-income countries. Clinical trials are now, though, increasingly being done in less wealthy countries. While this is welcome, there is a need to ensure the profit motive does not override the benefits. Partnership with local counterparts while adhering to international standards should help to maintain high-quality output from clinical trials.

Sign in / Sign up

Export Citation Format

Share Document